Trial Profile
Prevention of Poststroke Depression after Ischemic Stroke Using the Selective Serotonin Reuptake-Inhibitor Sertraline (PreDIS study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2006
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Acronyms PreDIS
- 15 Mar 2006 New trial record.